{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:09:59Z","timestamp":1779912599037,"version":"3.53.1"},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":5688,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine"],"published-print":{"date-parts":[[1992,12]]},"abstract":"<jats:p><jats:bold>SUMMARY. <\/jats:bold> Blood samples from 9,215 blood donors in three U.K. centres (North London, Bristol and Manchester) were tested for their alanine aminotransferase (ALT) level and the presence of anti\u2010HBc and anti\u2010HCV. This paper presents the results of the ALT and anti\u2010HBc tests. The prevalence of ALT &gt;45 IU\/1 was 3.1% overall (North London 3.06%, Bristol 4.56% and Manchester 1.97%). Manchester results were skewed by the methodology used for ALT measurement, highlighting the need for standard test methods. Anti\u2010HBc was detected using the Wellcome enzymeimmunosorbent assay (EIA) and confirmatory testing was performed using a radioimmunoassay (RIA) and the Corecell haemagglutination assay. Repeat reactive rates were 0.9, 0.79 and 0.94% for North London, Bristol and Manchester, respectively, with an overall rate of 0.9%. The confirmed positive rate was 0.73, 0.53 and 0.65% for the three centres with an overall rate of 0.63%. Donors with an ALT &gt;45 IU\/1, or with confirmed anti\u2010HBc, were interviewed with a medical questionnaire for risk factors. The major contributing factors in donors with a raised ALT were alcohol consumption and obesity.<\/jats:p>","DOI":"10.1111\/j.1365-3148.1992.tb00174.x","type":"journal-article","created":{"date-parts":[[2008,4,10]],"date-time":"2008-04-10T10:19:42Z","timestamp":1207822782000},"page":"301-310","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["U.K. multicentre study on blood donors for surrogate markers of non\u2010A non\u2010B hepatitis. Part I: Alanine transferase and anti\u2010HBc testing"],"prefix":"10.1111","volume":"2","author":[{"given":"N. A. B.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Raafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. H.","family":"Shwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. D.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. H.","family":"Gunson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Martlew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Mijovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Goldie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bendle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Paver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198104233041701"},{"key":"e_1_2_1_3_1","first-page":"522","article-title":"Comparison of three kits for antibodies to hepatitis B core antigen (anti\u2010HBc)","volume":"27","author":"Akins R.","year":"1987","journal-title":"Transfusion"},{"key":"e_1_2_1_4_1","first-page":"47","volume-title":"Infection, Immunity and Blood Transfusion","author":"Alter H.J.","year":"1985"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(89)70071-7"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jama.1981.03320060032017","article-title":"Donor transaminase and recipient hepatitis. Impact on Blood Transfusion Service","volume":"246","author":"Alter H.J.","year":"1981","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_1_7_1","first-page":"1","article-title":"American Association of Blood Banks reaffirms decision to require ALT and anti\u2010HBc testing","volume":"4","author":"Anonymous","year":"1987","journal-title":"Blood Bank Week"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1989.29389162729.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1989.29189101157.x"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1983.tb03661.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562"},{"key":"e_1_2_1_12_1","first-page":"1163","article-title":"Liver enzymes and long distance running","volume":"36","author":"Dietmar N.","year":"1990","journal-title":"Clinical Chemistry"},{"key":"e_1_2_1_13_1","first-page":"307","article-title":"Will the real hepatitis C stand up","author":"Editorial","year":"1989","journal-title":"Lancet"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90485-6"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-137"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1988.tb03890.x"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1987.27187121451.x"},{"key":"e_1_2_1_18_1","volume-title":"That's the Limit","author":"Health Education Authority","year":"1989"},{"key":"e_1_2_1_19_1","first-page":"69","volume-title":"Transfusion Transmitted Viruses: Epidemiology and pathology","author":"Hollinger F.B.","year":"1987"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/oxfordjournals.aje.a113380","article-title":"The distribution of serum alanine aminotransferase levels in a blood donor population","volume":"115","author":"Kahn R.A.","year":"1982","journal-title":"Americal Journal of Epidemiology"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-4-488"},{"key":"e_1_2_1_22_1","first-page":"294","article-title":"Antibodies to Hepatitis C Virus in German blood donors","author":"Kuhnl P.","year":"1989","journal-title":"Lancet"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2496467"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.40.11.1340"},{"key":"e_1_2_1_25_1","volume-title":"ABC of Alcohol","author":"Paton A.","year":"1988"},{"key":"e_1_2_1_26_1","first-page":"558","volume-title":"Viral Hepatitis and Liver Disease","author":"Reesink H.W.","year":"1988"},{"key":"e_1_2_1_27_1","volume-title":"Diseases of the Liver and Biliary System","author":"Sherlock S.","year":"1981"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-6-733"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890060407"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1987.27587320541.x"},{"key":"e_1_2_1_31_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0140-6736(89)90486-8","article-title":"Anti\u2010hepatitis C antibodies and non\u2010A, non\u2010B post transfusion hepatitis in the Netherlands","author":"Poel C.L.","year":"1989","journal-title":"Lancet"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1988.tb03891.x"}],"container-title":["Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3148.1992.tb00174.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3148.1992.tb00174.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T18:56:30Z","timestamp":1695840990000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3148.1992.tb00174.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1992,12]]}},"alternative-id":["10.1111\/j.1365-3148.1992.tb00174.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3148.1992.tb00174.x","archive":["Portico"],"relation":{},"ISSN":["0958-7578","1365-3148"],"issn-type":[{"value":"0958-7578","type":"print"},{"value":"1365-3148","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,12]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}